Mometasone furoate 110mcg/inh, 220mcg/inh; pwd for oral inhalation; with dose counter. Mometasone furoate is a corticosteroid demonstrating potent anti-inflammatory activity. The precise mechanism of ...
KENILWORTH, N.J., Aug. 19 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) announced today that ASMANEX(R) TWISTHALER(R) 110 mcg (mometasone furoate ...
Asmanex Twisthaler has been launched by Schering-Plough as therapy in the control and management of mild, moderate or severe persistent asthma in Asmanex Twisthaler has been launched by ...
The FDA has approved Asmanex Twisthaler (mometasone furoate inhalation powder, from Schering-Plough) 110 mcg for the maintenance treatment of asthma as a preventive therapy in patients 4-11 years of ...